Navigation Links
Technology May Explain Mammogram's Poorer Performance in Younger Women
Date:7/28/2010

By Kathleen Doheny
HealthDay Reporter

TUESDAY, July 27 (HealthDay News) -- The poorer tumor detection rate offered by mammography for women in their 40s is due more to the technology itself than characteristics of a younger woman's cancer, according to a new study.

For years, experts have known that mammography's performance is poorer for women in their 40s versus older women, and they've placed much of the blame on the notion that tumors typically grow faster in younger women.

That would mean that by the time they are at a size detectable by mammogram, these tumors would have already been detected by a routine clinical exam, anyway. Younger women's breast tissue is also denser, which can make it easier for tumors to ''hide" on a mammogram.

But others have suspected that mammography's poorer performance among younger women is due more to the limits of the technology.

The issue is particularly pressing since experts at the U.S. Preventive Services Task Force updated their breast cancer screening guidelines last November. Those guidelines advised that normal-risk women in their 40s no longer get a yearly mammogram. The decision set off a firestorm of controversy that has not yet abated.

In the meantime, why are mammograms less apt to spot disease in younger women?

"I set out to find out -- is it the difference in [women's] biology or technology?" said Sylvia Plevritis, associate professor of radiology at the Stanford University School of Medicine, Stanford, Calif.

With her colleagues, she developed a breast cancer screening simulator, a computer simulation model that could estimate the relative contributions of factors such as tumor growth versus tumor detectability on a mammogram.

Plevritis drew on data for about 100,000 women from the SEER database (Surveillance, Epidemiology and End Results), a widely used source of health information. Her team looked at women aged 40 to 49 and women aged 50 to 69.

''This analysis says the limiting factor is not the difference in doubling time of the breast cancer," Plevritis concluded. "The limiting factor is the ability of the mammogram to detect the tumor."

She pointed out that she studied women who had conventional mammograms only. "Technology with conventional mammography is just not sensitive enough," Plevritis said. "That explains 79 percent of the reduced detection rate." The characteristics of the cancer itself in younger women account for just 21 percent of the shortfall in detection, the model found.

The findings were published online July 27 in the The Journal of the National Cancer Institute.

Plevritis said that because she evaluated women who had conventional mammography only, the results may be different with more advanced digital mammography. Some research has found digital more accurate in detecting tumors in women 40 to 49, she said.

That's beyond the scope of her paper, "but our work is suggesting that the performance of digital mammography in younger women will make a difference," Plevritis said.

Another limitation of her study, she said, is that they looked at only invasive disease, not the early form of breast cancer known as ductal carcinoma in situ or DCIS. "The natural history of DCIS is not well understood," she said.

For now, she said, younger women below age 50 might consider asking for digital mammograms. Advances in technologies are needed, she said, to better detect breast cancers in younger women.

More information

There's more on breast cancer screening at the American Cancer Society.

SOURCES: Sylvia Plevritis, Ph.D., associate professor, radiology, Stanford University School of Medicine, Stanford, Calif.; July 27, 2010, Journal of the National Cancer Institute


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nanotechnology for water purification
2. Technology for locating first responders in buildings to be showcased at national workshop
3. Researchers cut years from drug development with nanoscopic bead technology
4. Brookhaven Lab and BioSET Inc. patent improved growth factor technology
5. USF receives patent for technology to improve treatment for neurodegenerative diseases
6. IVR Technology Group Announces MobileMarketing123.com
7. CellTrak Mobile Technology Improves Client Care in Vancouver for the Community Home Support Services Association
8. OEM Partnership Between Thought Technology Ltd. and Mediwatch plc
9. Neuxpower Selected as 2010 Emerging Technology Vendor by CRN Magazine
10. New scanning technology developed in £7M research center
11. Europe leads the world in assisted-reproduction technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Technology May Explain Mammogram's Poorer Performance in Younger Women
(Date:2/8/2016)... , ... February 08, 2016 , ... ... its newly redesigned website, federallabs.org . The site houses a wealth of ... available federal technologies through the process called technology transfer (T2). As a network ...
(Date:2/8/2016)... ... ... famous for gift giving with flowers, chocolates and other tokens of affection meant to remind ... than 5.6 million Americans suffering with Alzheimer’s, those store bought gifts - no matter ... they’ve led and the people they’ve touched. , That’s why Give To ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... and clothing, announced expansion into Canada to provide its range of unique and ... sales office in Quebec City that will provide bilingual customer service and marketing ...
(Date:2/8/2016)... , ... February 08, 2016 , ... Delta Dental of ... help combat pancreatic cancer. , Gary D. Radine, who recently retired as president and ... American Cancer Society’s 2015 CEO of the Year , helped lead the effort ...
(Date:2/8/2016)... ... 08, 2016 , ... FileHold's document management software has been ... cloud hosted environment for FileHold software that is pay per user subscription-based and ... using the FileHold web services API. DocuSyst also advises clients on fully functioning ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... that the U.S. Food and Drug Administration (FDA) ... application for SB-318, a single treatment strategy intended ... I (MPS I). The SB-318 IND application is ... Phase 1/2 clinical study (SB-318-1502) designed to assess ...
(Date:2/8/2016)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA:CTIC) today announced ... Food and Drug Administration (FDA) on February 4, 2016, ... on the clinical studies being conducted under the Company,s ... hold impacts part of the clinical work currently being ... clinical trials. --> ...
(Date:2/5/2016)... Feb. 5, 2016 Amgen (NASDAQ: AMGN ) ... Global Healthcare Conference at 9:15 a.m. ET on Wednesday, Feb. ... David W. Meline , executive vice president and chief ... audio of the presentation can be accessed from the Events ... replay of the webcast will also be available on Amgen,s ...
Breaking Medicine Technology: